Mintz has advised Lisata Therapeutics. Lisata Therapeutics, a clinical-stage pharmaceutical company, has closed a $225 million private placement financing as part of a transaction that combines...
Lisata Therapeutics Completes $225 Million Private Placement
Lisata Therapeutics Acquires Marea Therapeutics
Mintz has advised Lisata Therapeutics. Goodwin Procter served Marea Therapeutics. Cooley assisted the placement agents. Lisata Therapeutics, Inc. (Nasdaq: LSTA) a clinical-stage pharmaceutical company, has acquired...
FORTE Acquires Vega Global to Expand Global Audiovisual Solutions Presence
Eversheds Sutherland has advised Baird Capital on the sale of Vega Global Group to FORTE. Baird Capital has completed the sale of Vega Global Group, the...
uniQure Completes $259 Million Public Offering of Ordinary Shares
Morgan, Lewis & Bockius LLP, NautaDutilh N.V., Van Campen Liem, Nederlandsch Octrooibureau, and Clark & Elbing, LLP have advised uniQure. Mintz has advised the underwriters. uniQure...
SAB Biotherapeutics Completes $85 Million Public Offering
Dentons has advised SAB Biotherapeutics, Inc. Mintz has advised the underwriters. SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin...
Eupraxia Pharmaceuticals Closes US$63.2 Million Public Offering
Mintz and Stikeman Elliott LLP have advised the underwriters. Troutman Pepper and Blake, Cassels & Graydon LLP have advised Eupraxia Pharmaceuticals. Eupraxia Pharmaceuticals Inc., a clinical-stage...
Protara Therapeutics Prices $75 Million Public Offering
Kirkland & Ellis LLP has advised Protara Therapeutics, Inc. Mintz has advised the underwriters. Protara Therapeutics, Inc., a clinical-stage company focused on transformative therapies for cancer...
Fulcrum Therapeutics Prices $175 Million Public Offering of Stock and Pre-Funded Warrants
Goodwin Procter LLP has advised Fulcrum Therapeutics. Mintz has advised the underwriters. Fulcrum Therapeutics, Inc. (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company, has announced the pricing...
Eledon Pharmaceuticals Prices $50 Million Public Offering of Common Stock and Pre-Funded Warrants
O’Melveny & Myers LLP has advised Eledon Pharmaceuticals, Inc. Mintz has advised the underwriters. Eledon Pharmaceuticals, Inc. (Nasdaq: ELDN), a clinical-stage biotechnology company, has announced the...
uniQure Completes $345 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Mintz has advised the underwriters on the offering. uniQure N.V. (Nasdaq: QURE) has completed a public offering valued at approximately $345 million. The offering consisted of...
Prenetics’ $200 Million Joint Venture with Professor Dennis Lo
Baker McKenzie advised Prenetics Global Limited on the deal. Prenetics Global Limited, a leading genomics-driven health sciences company listed on Nasdaq, created a USD 200 million joint...